Page last updated: 2024-11-01

ondansetron and Leukemia, Pre-B-Cell

ondansetron has been researched along with Leukemia, Pre-B-Cell in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"Ondansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy."7.74Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. ( Pinsk, M; Turner, SR, 2008)
"Ondansetron is a commonly used medication in the treatment of nausea and vomiting arising from many etiologies, including chemotherapy."3.74Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL. ( Pinsk, M; Turner, SR, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghafouri, N1
Darracq, MA1
Cantrell, FL1
Turner, SR1
Pinsk, M1

Other Studies

2 other studies available for ondansetron and Leukemia, Pre-B-Cell

ArticleYear
Ondansetron-associated hypotension following pediatric self-poisoning.
    Pediatric emergency care, 2012, Volume: 28, Issue:6

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Overdose; Emergencies; Huma

2012
Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cytarab

2008